Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Benecol softgel relaunch

This article was originally published in The Tan Sheet

Executive Summary

McNeil Nutritionals will test-launch new version of Benecol softgels in late 2002, with possible expansion in 2003, J&J Consumer Pharmaceuticals & Nutritional Products Chairman Brian Perkins tells analysts Sept. 23. Different formulation of softgels was launched in 1999 but later discontinued. Plant stanol esters spread has been sold as a functional food since FDA frowned upon J&J division's early attempts to market product as a dietary supplement. Labeling claims, such as "reduce your LDL cholesterol by up to 14%," likely would not be feasible for a supplement version...

You may also be interested in...



Benecol Smart Chews To Hit Shelves Nationwide In Early 2005

McNeil Nutritionals is expanding its Benecol cholesterol-lowering supplement line with a new soft chew formula, the firm said Sept. 28

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy

The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel